Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57PHILADELPHIA, March 09, 2026 (GLOBE NEWSWIRE) -- Medicus...
Vaccine
Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the publication of data from...
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
Burlington, Ontario--(Newsfile Corp. - March 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company...
Evaxion plans to file 2025 annual report later today
COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its...
Patent Award Marks Key Milestone for Delta Development Team’s Autonomous Portable Refrigeration Unit
TUCSON, Ariz., March 4, 2026 /PRNewswire/ -- Delta Development Team, Inc., an industry leader in ruggedized thermal systems for medical...
ICAN Poll: Overwhelming Majority of Respondents Oppose Glyphosate Stockpiling, Reject Manufacturer Immunity
New public opinion data from 2,569 respondents reveals near-unanimous opposition to key provisions of the administration’s glyphosate executive order ICAN...
Drug Discovery Leader Marcus Schindler Joins Cradle’s Advisory Board
Former Novo Nordisk CSO partners with Cradle to speed design and development of therapeutics with enterprise-grade AI protein engineering platformAMSTERDAM...
Imviva Biotech Announces Acceptance of Late-Breaking Abstract Highlighting Data from Ongoing Phase 1/2 Study of CTA313 at 15th European Lupus Meeting
Novel allogeneic CAR-T therapy demonstrates durable remission and immune-reset mechanism in systemic lupus erythematosusBOSTON, March 02, 2026 (GLOBE NEWSWIRE) --...
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
COPENHAGEN, Denmark, March 2, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its...
European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
mCOMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending marketing authorization and...
Study finds more parents saying ‘No’ to vitamin K, putting babies’ brains at risk
Highlights:A new review of research has found the number of parents refusing vitamin K injections for their newborns is on...
Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize
A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat...
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
Burlington, Ontario--(Newsfile Corp. - February 23, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a...
Moderna to Present at Upcoming Conferences in March 2026
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following...
QuantiPath Introduces Turkey KPI Kits to Strengthen Salmonella Detection and Quantification
DENVER, Feb. 18, 2026 /PRNewswire/ -- QuantiPath, a leader in rapid, quantitative food safety diagnostics, today announced the availability of...
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics license...
Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion
YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / February 17, 2026 / Alpha Genesis, Inc., America's largest primate research center, proudly...
Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion
YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / February 17, 2026 / Alpha Genesis, Inc., America's largest primate research center, proudly...
African Leaders Call for Sustainable Malaria Financing as Progress Stalls and Funding Crisis Deepens
The 2025 Africa Malaria Progress Report reveals 270.8 million cases and nearly 600,000 deaths; It warns of potential resurgence, as...
Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE,...